Status:
COMPLETED
Modafinil for the Treatment of Cocaine Dependence - 1
Lead Sponsor:
National Institute on Drug Abuse (NIDA)
Conditions:
Cocaine-Related Disorders
Eligibility:
All Genders
18-99 years
Phase:
PHASE2
Brief Summary
The purpose of this study is to evaluate the efficacy and safety of modafinil in reducing cocaine use in subjects with cocaine dependence.
Detailed Description
This is a double-blind, placebo-controlled, parallel group design study to evaluate the efficacy and safety of modafinil in reducing cocaine use in subjects with cocaine dependence.
Eligibility Criteria
Inclusion
- Participant must have DSM-IV diagnosis of cocaine dependence as determined by SCID.
- Must be seeking treatment for cocaine dependence.
- Must be able to understand and provide written informed consent.
Exclusion
- Please contact the study site for more information.
Key Trial Info
Start Date :
October 1 2004
Trial Type :
INTERVENTIONAL
End Date :
December 1 2006
Estimated Enrollment :
210 Patients enrolled
Trial Details
Trial ID
NCT00100100
Start Date
October 1 2004
End Date
December 1 2006
Last Update
January 12 2017
Active Locations (6)
Enter a location and click search to find clinical trials sorted by distance.
1
Boston University Medical Center
Boston, Massachusetts, United States, 02215
2
New York VA Medical Center
New York, New York, United States, 10010
3
Cincinnati Addiction Research Center
Cincinnati, Ohio, United States, 45220 2272
4
Western Psychiatric Institute & Clinic
Pittsburgh, Pennsylvania, United States, 15213 2593